InsidersTradesSigma
Track the 넥스트바이오메디컬 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 넥스트바이오메디컬 has published 1 insider filings. Market capitalisation: €281.8bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: 넥스트바이오메디컬. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
넥스트바이오메디컬 是一家在 XKRX 市场上市的公司，专注于医疗保健和制药领域。该公司致力于开发创新解决方案以提升医疗保健水平。